molecular glue discovery

Bullseye Biosciences is a therapeutics discovery company that uses directed evolution inside living cells to discover functional molecules against challenging intracellular targets. Its platform combines in-cell directed evolution with automation and Next Generation Sequencing to enable scalable discovery, generating functionally annotated datasets. The company is progressing a lead program toward in vivo evaluation and is expanding into intracellular targets across oncology, immunology, and beyond.

Read more

automationin-cell directed evolutionintracellular selection systemsmulti-protein complex stabilizationnext-generation sequencingprotein interaction disruption

CDI Labs provides proteomic products and services for autoantibody profiling, biomarker discovery, target identification, and antibody development. Its platforms include the HuProt™ Human Proteome Microarray (21,000+ full-length human proteins) and PhIP-Seq services such as HuScan®, MouseScan™, VirScan®, and VirScan® Exposome. The company also offers specialized CRO services including antibody development, protein production, cell therapy, and immunogenicity testing.

Read more

antibody developmentbiomarker discoverycell therapyCRISPR-Cas9 immunogenicity testingdiagnostic developmentimmunogenicity testingpan-proteome epitope mappingPhIP-Seqpost-translational modification specificity profilingprotein microarrayprotein productionproteome-wide autoantibody profilingtarget identification